Home Reimbursed medicines Aflibercept
Aflibercept — maximum prices and reimbursement
The CANAMED catalogue contains 20 medicines with the active substance Aflibercept, from 9 manufacturers. Below you can see each entry with the brand name, the manufacturer, the maximum retail price, the reimbursement percentage and the prescription status — plus live pharmacy prices, where we track them.
In short: for the active substance Aflibercept there are 20 authorised medicines in the CANAMED catalogue, with maximum retail prices between 1316.42 and 3316.30 RON, from 9 manufacturers. For 10 of them the catalogue also records the reimbursement percentage. The maximum price is the legal cap — pharmacies may sell below it, so it is worth comparing the real price before you go. Latest import: 2026-11-03.
Data verified on from public sources (OpenStreetMap, chain websites, ANM/MS) — updated daily.
CANAMED catalogue
All medicines with Aflibercept
Maximum retail price = the legal selling cap. Sorted by price, lowest first.
| Brand name | Manufacturer | Maximum price | Reimbursement | Prescription |
|---|---|---|---|---|
| ZALTRAP 25 mg/ml | SANOFI-AVENTIS DEUTSCHLAND GMBH - GERMANIA | 1316.42 RON | 100% · C2 (national programmes) CNAS pays ~1316.42 RON; you ~0.00 RON* |
PR |
| EYDENZELT 40 mg/ml | NUVISAN FRANCE SARL - FRANTA | 1401.99 RON | 100% · C1 (certain chronic diseases) CNAS pays ~1401.99 RON; you ~0.00 RON* |
PR |
| EYDENZELT 40 mg/ml | NUVISAN FRANCE SARL - FRANTA | 1560.75 RON | 100% · C1 (certain chronic diseases) CNAS pays ~1560.75 RON; you ~0.00 RON* |
PR |
| MYNZEPLI 40 mg/ml | ALVOTECH HF - ISLANDA | 1560.76 RON | 100% · C1 (certain chronic diseases) CNAS pays ~1560.76 RON; you ~0.00 RON* |
PR |
| EYLEA 40 mg/ml | BAYER AG - GERMANIA | 1872.86 RON | 100% · C1 (certain chronic diseases) CNAS pays ~1682.39 RON; you ~190.47 RON* |
PR |
| OPUVIZ 40 mg/ml | SAMSUNG BIOEPIS NL B.V. - OLANDA | 1872.90 RON | 100% · C1 (certain chronic diseases) CNAS pays ~1682.39 RON; you ~190.51 RON* |
PR |
| AFQLIR 40 mg/ml | ALCON-COUVREUR N.V. - BELGIA | 2021.08 RON | 100% · C1 (certain chronic diseases) CNAS pays ~1682.39 RON; you ~338.69 RON* |
PR |
| AFQLIR 40 mg/ml | ALCON-COUVREUR N.V. - BELGIA | 2123.61 RON | 100% · C1 (certain chronic diseases) CNAS pays ~1682.39 RON; you ~441.22 RON* |
PR |
| AHZANTIVE 40 mg/ml | FORMYCON AG - GERMANIA | 2124.86 RON | not reimbursed | PR |
| ZALTRAP 25 mg/ml | SANOFI-AVENTIS DEUTSCHLAND GMBH - GERMANIA | 2611.03 RON | 100% · C2 (national programmes) CNAS pays ~2611.03 RON; you ~0.00 RON* |
PR |
| EYLEA 40 mg/ml | BAYER AG - GERMANIA | 3255.28 RON | not reimbursed | PR |
| EYLEA 114,3 mg/ml | BAYER AG - GERMANIA | 3316.30 RON | 100% · C1 (certain chronic diseases) CNAS pays ~3316.30 RON; you ~0.00 RON* |
PR |
| EYLEA 114,3 mg/ml | BAYER AG - GERMANIA | — | not reimbursed | PR |
| MYNZEPLI 40 mg/ml | ALVOTECH HF - ISLANDA | — | not reimbursed | PR |
| PAVBLU 40 mg/ml | AMGEN TECHNOLOGY (IRELAND) UC - IRLANDA | — | not reimbursed | PR |
| PAVBLU 40 mg/ml | AMGEN TECHNOLOGY (IRELAND) UC - IRLANDA | — | not reimbursed | PR |
| YESAFILI 40 mg/ml | BIOSIMILAR COLLABORATIONS IRELAND LIMITED - IRLANDA | — | not reimbursed | PR |
| YESAFILI 40 mg/ml | BIOSIMILAR COLLABORATIONS IRELAND LIMITED - IRLANDA | — | not reimbursed | PR |
| YESAFILI 40 mg/ml | BIOSIMILAR COLLABORATIONS IRELAND LIMITED - IRLANDA | — | not reimbursed | PR |
| ZALTRAP 25 mg/ml | SANOFI-AVENTIS DEUTSCHLAND GMBH - GERMANIA | — | not reimbursed | PR |
Reimbursement and amounts come from the CNAS nomenclature (SIUI) valid in the current month, for each pack. *What you pay is indicative: the maximum price minus what CNAS pays on the main sublist, for an insured adult. The pharmacy may sell below the maximum price; low-income pensioners, children, pupils and pregnant women may pay less. C1 applies only to the diseases on the list, and C2 within the national programmes.
Prescription status key:
- PR — With a medical prescription (PR)
Live pharmacy prices
Products with Aflibercept in our comparator
Shelf prices collected from the large chains — see on each product page where it is cheapest.
Good to know
How to read the maximum price
The CANAMED maximum retail price is the legal cap approved by the Ministry of Health — the pharmacy may sell for less, never for more. If the medicine is reimbursed, the sublist percentage (A 90%, B 50%, C1/C2 100%, D 20%) applies to the reference price of the therapeutic group, usually calculated from the cheapest product with the same INN — which is why your contribution can differ from one brand to another, even for the same active substance. The electronic prescription automatically shows the exact amount to pay; for non-prescription shelf prices, use the HartaFarmacii comparator.
CANAMED catalogue
Other active substances in the catalogue
- Apixaban
- Atorvastatin
- Atomoxetin
- Aripiprazol
- Abirateron
- Amoxicillin + acid clavulanic
- Allopurinol
- Amlodipin
- Adalimumab
- Aciclovir
See also the full list of reimbursed medicines, with an alphabetical index of all active substances.
Frequently asked questions
FAQ · Aflibercept
-
Is Aflibercept reimbursed?
Yes. For 10 of the catalogue entries with Aflibercept we have the reimbursement percentage on record. The percentage depends on the CNAS sublist each product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and applies to the reference price of the therapeutic group, not to the shelf price. Ask the doctor or pharmacist for the exact placement. -
What is the CANAMED maximum price for Aflibercept?
The maximum retail prices (the CANAMED legal cap) for medicines with Aflibercept are between 1316.42 and 3316.30 RON. No pharmacy may sell above the maximum price, but it may sell below it — compare real prices with the HartaFarmacii comparator. -
What percentage of Aflibercept is reimbursed?
The percentage depends on the CNAS sublist: A 90% (common chronic diseases), B 50% (partial reimbursement), C1 and C2 100% (serious chronic diseases and national programmes), D 20%. The percentage applies to the reference price set by CNAS, not to the shelf price, so you may pay a difference even for a “100% reimbursed” medicine. You can see the exact placement on the electronic prescription. -
How many medicines with Aflibercept are in the CANAMED catalogue?
The CANAMED catalogue holds 20 authorised medicines with the active substance Aflibercept — different brand names, strengths and pharmaceutical forms. You will find them all, with maximum price and prescription status, in the table on this page. Latest CANAMED import into the HartaFarmacii database: 2026-11-03.
Before you go